Publicacións nas que colabora con Margus Punab (103)

2024

  1. Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study

    Reviews in Endocrine and Metabolic Disorders

  2. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants

    The Lancet, Vol. 404, Núm. 10455, pp. 851-863

  3. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains

    Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014

  4. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

    Aging Male, Vol. 27, Núm. 1

  5. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

    The Lancet, Vol. 403, Núm. 10431, pp. 1027-1050

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study

    BMC Geriatrics, Vol. 23, Núm. 1

  3. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  4. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532

2022

  1. Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 3, pp. e1212-e1220

  2. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

    Andrology, Vol. 10, Núm. 7, pp. 1328-1338

  3. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status

    Age and ageing, Vol. 51, Núm. 4

  4. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

    Physiology and Behavior, Vol. 252

  5. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

    Frontiers in Endocrinology, Vol. 13

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831

  3. Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study

    Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919

  4. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

    The Lancet, Vol. 398, Núm. 10304, pp. 957-980

2020

  1. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

    The Lancet, Vol. 396, Núm. 10261, pp. 1511-1524

  2. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77